1
Registered and consented patients with moderate or severe HA or HB without inhibitors were included.
2
We report a new protocol for consenting patients.
3
Tumor blocks were obtained from 711 consenting patients.
4
Measurement: Data were collected over 6-months of follow-up from consenting patients' medical records and telephone interviews with patients.
5
Fifty-three consenting patients meeting clinical and urine composition criteria for established intrinsic ARF were assigned to two treatment groups.
6
A total of 320 consenting patients with capacity will be recruited from the community, general practitioner clinics and psychiatric units.
7
Consenting patients underwent serologic screening with endomyslal antibody and tissue transglutaminase antibody testing and Intestinal biopsies to confirm the diagnosis of CD.
8
One hundred and one consenting patients undergoing elective CABG surgery at a single tertiary cardiac centre were recruited into two randomised controlled, single-blinded clinical studies.
9
Electrophysiological studies in seven consenting patients, 9 to 16 months following ASD closure showed normal atrial potentials from the site of the patch.
10
Three screening (SC) groups, including all consented patients aged 17-20, 35-40 and 60-65 years, and patients referred (RF) for clinical indications underwent focused echo.